ViCentra names Ian Wells CFO, adds Thomas A. West to board

The medical device company said the hires follow a $98 million Series D, commercial-scale Kaleido manufacturing and preparations to expand in Europe and enter the U.S. market.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.